Point-of-Care Testing

Correlation between Standard Clinical Chemistry and Point of Care Testing Analyzers on Hemoglobin A1C Determination

Point-of-Care Testing and Creatinine Measurement.

This paper reviews the current status of point-of-care testing (PoCT) devices that are available for measuring whole blood or serum/plasma creatinine globally and within Australasia. Information on non-analytical specifications and analytical performance is provided using data sourced from recently published literature, external quality assurance programs and evaluative work by the author's uni...

Guidelines for point-of-care testing: haematology.

This guideline provides a framework for the arrangement of point-of-care testing (POCT) services, previously known as near patient testing (patient self-testing not covered). POCT is defined as any analytical test performed outside the laboratory. Primary users are often non-laboratory healthcare workers. The guidance applies to units within hospitals as well as general practioner surgeries, co...

Risk Management for Point-of-Care Testing

Point-of-care testing (POCT) is growing in popularity, and with this growth comes an increased chance of errors. Risk management is a way to reduce errors. Originally developed for the manufacturing industry, risk management principles have application for improving the quality of test results in the clinical laboratory. The Clinical and Laboratory Standards Institute (CLSI), EP23-A Laboratory ...

Point-of-care testing: is faster better?

Does the faster turnaround time for point-of-care testing (POCT) lead to better outcomes? Do the benefits justify the usually higher reagent costs and the expense and complexity of regulatory compliance? The answer, after 20 years of investigation, is an unequivocal " It depends. " It depends on the analyte and the testing device, on the reasons for testing, and on the setting of the testing, a...